- 主题
- 392
- 您的身份
- 病友
- 就诊医院
- 北京协和
- 病理报告
- 滤泡性淋巴瘤1-2级
- 目前状态
- 康复10-20年
参加活动:0 次 组织活动:0 次
您的身份病友
病理报告滤泡性淋巴瘤1-2级
就诊医院北京协和
目前状态康复10-20年
最后登录2025-9-1
  
|
发表于 昨天 13:33
|
显示全部楼层
来自: 中国北京
NLPBL is typically an indolent disease, and late recurrences beyond 10 years can be seen. Nevertheless, the prognosis of patients with NLPBL is excellent, with low excess mortality compared with the general population. In these patients, lymphoma does not represent the major cause of death. The management differs from that of CHL for both early and advanced stages and is similar to the approach used in indolent B-cell NHLs.
Disease-related morbidity and mortality often result from therapy rather than from disease progression; thus, avoiding overtreatment is important. The hope is that the change in nomenclature from NLPHL to NLPBL might help achieve this goal.
这是ICC分类中关于这种疾病的两段描述,非常有意思,大致是说,结节性淋巴细胞为主B细胞淋巴瘤是一种惰性疾病,10年后复发的也有,但预后极好,超额死亡率不高于普通人群,并发疾病和死亡经常是由于治疗的原因而不是疾病本身的原因。
|
|